Vaudaux B, Steinemann M A
Schweizerische Kommission für Impffragen, Lausanne.
Soz Praventivmed. 1998;43 Suppl 1:S47-56, S121-9. doi: 10.1007/BF02042176.
The purpose of this study is to assess Swiss physicians' knowledge on hepatitis B, their perception of parental information concerning this infection, their attitude towards planned universal vaccination, and their agreement with different universal immunisation scenarios. Vaccination scenarios were assessed in the following groups: infants, children at school entry, children aged 11 to 13, and children aged 14 to 16. Furthermore, scenarios involving the immunisation of school-aged children included the administration of the vaccine doses by the child's private physician or by the school health officer. Questionnaires were mailed to members of the Swiss Society of Pediatrics (n = 994), to a random sample of family physicians (n = 1000), to internists practicing general medicine (n = 500), and to chief medical officers of school health services in nine major Swiss cities. Physicians reported that they were sufficiently well informed on the serious potential sequelae of hepatitis B and the efficacy of vaccine prevention, but insufficiently informed on its epidemiology. They do not fundamentally disagree with the introduction of universal immunisation and think that parents are not aware of the potential long term dangers associated with this infection. Pediatricians and general practitioners believe that vaccinating infants at the cost of three extra injections would not be accepted by their peers and parents, and that immunising older children in their office would be feasible though difficult. School health officers believe that the immunisation of children aged 14 to 16 within the school health setting would be feasible. Universal vaccination of older children and adolescents is the scenario that best fits Switzerland's needs, perceptions and present circumstances.
本研究的目的是评估瑞士医生对乙型肝炎的了解程度、他们对家长关于这种感染的信息的认知、他们对计划中的普遍疫苗接种的态度,以及他们对不同普遍免疫方案的认同度。在以下几组人群中评估了疫苗接种方案:婴儿、入学儿童、11至13岁儿童以及14至16岁儿童。此外,涉及学龄儿童免疫接种的方案包括由儿童的私人医生或学校卫生官员接种疫苗。问卷被邮寄给瑞士儿科学会成员(n = 994)、家庭医生随机样本(n = 1000)、从事普通内科的内科医生(n = 500)以及瑞士九个主要城市的学校卫生服务首席医疗官。医生们报告称,他们对乙型肝炎严重的潜在后遗症和疫苗预防效果有充分了解,但对其流行病学了解不足。他们基本上不反对引入普遍免疫,并认为家长并未意识到与这种感染相关的潜在长期危险。儿科医生和全科医生认为,以额外三针注射为代价给婴儿接种疫苗不会被同行和家长接受,而在他们的诊所为大龄儿童接种疫苗虽然困难但可行。学校卫生官员认为,在学校卫生环境中为14至16岁儿童接种疫苗是可行的。对大龄儿童和青少年进行普遍疫苗接种是最符合瑞士需求、认知和当前情况的方案。